ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronEye IconIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintSite TitleTitle ChevronIcon Twitter
Process Industries

Mitsubishi Chemical Holdings Corp.

Business Summary

Mitsubishi Chemical Holdings Corp. engages in the management of its group companies. It operates through the following segments: Electronic Applications, Designed Materials, Health Care, Chemicals, Polymers and Others. The Electronic Applications segment covers recording media and electronic-related products. The Designed Materials segment offers polyester films, food ingredients, films, fine chemicals, polymer processing products, composite materials, inorganic chemicals, water treatment systems, and chemical fibers. The Health Care segment manufactures and sells pharmaceuticals, diagnostic reagents, and clinical testing products. The Chemicals segment deals with basic chemical and carbon products. The Polymers segment produces synthetic resins. The Others segment includes engineering, transportation, and warehousing services. The company was founded on October 3, 2005 and is headquartered in Tokyo, Japan.

Financial Highlights

Mar 2019 JPYUSD
Gross Profit1,101.55B9,933.34M
Operating income300,861M2,713.03M
Income before tax288,056M2,597.56M
Net income169,530M1,528.74M
Diluted EPS110.040.99
Dividends Per Share400.36
Total Assets5,572.50B50,345.65M
Total liabilities3,546.65B32,042.77M
Total equity1,377.94B12,449.26M
Operating cash flow415,575M3,747.47M
Currency in JPYCurrency in USD

Historical Data

 Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019
Revenue 3,656.27B 3,543.35B 3,376.05B 3,724.40B 3,923.44B
Gross Profit 830,081M 1,015.04B 1,009.39B 1,120.06B 1,101.55B
Operating income 165,681M 295,965M 287,903M 355,745M 300,861M
Income before tax 165,621M 238,808M 241,379M 344,077M 288,056M
Net income 60,859M 125,227M 153,673M 211,788M 169,530M
EBITDA 338,078M 478,621M 461,943M 534,640M 500,193M
Diluted EPS 41.38 35.03 105.95 136.05 110.04
Dividends Per Share 13 15 20 32 40
Total Assets 4,323.03B 4,223.77B 4,463.54B 4,701.41B 5,572.50B
Total liabilities 2,734.43B 2,627.62B 2,765.35B 2,781.92B 3,546.65B
Total equity 981,464M 972,197M 1,091.39B 1,285.75B 1,377.94B
Operating cash flow 329,776M 299,612M 396,643M 397,940M 415,575M
 Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019
Revenue 33,282.31M 29,507.20M 31,176.79M 33,603.94M 35,379.91M
Gross Profit 7,556.04M 8,452.80M 9,321.47M 10,105.90M 9,933.34M
Operating income 1,508.15M 2,464.64M 2,658.69M 3,209.75M 2,713.03M
Income before tax 1,507.61M 1,988.66M 2,229.05M 3,104.47M 2,597.56M
Net income 553.98M 1,042.82M 1,419.12M 1,910.88M 1,528.74M
EBITDA 3,077.45M 3,985.70M 4,265.89M 4,823.85M 4,510.52M
Diluted EPS 0.37 0.29 0.97 1.22 0.99
Dividends Per Share 0.11 0.12 0.18 0.28 0.36
Total Assets 36,047.84M 37,579.73M 40,056.95M 44,206.99M 50,345.65M
Total liabilities 22,801.22M 23,378.46M 24,816.92M 26,158.19M 32,042.77M
Total equity 8,183.98M 8,649.82M 9,794.47M 12,089.79M 12,449.26M
Operating cash flow 3,001.88M 2,495.01M 3,662.86M 3,590.46M 3,747.47M

Valuation Measures

Mar 2019
Operating margin7.66%
Profit margin4.32%

Key executives

  • President & Director: Hitoshi Ochi
  • CFO & Managing Executive Officer: Hidefumi Date
  • Director & Chief Compliance Officer: Ken Fujiwara
  • Executive Officer, Manager-Public Relations & IR: Hajime Takasaka
  • Manager-Business Administration: Motohiro Oki


  • Mitsubishi Chemical Holdings Corp. (5.5%)
  • Meiji Yasuda Life Insurance Co. (4.2%)
  • Sumitomo Mitsui Trust Asset Management Co., Ltd. (4.0%)
  • Nomura Asset Management Co., Ltd. (3.6%)
  • Asset Management One Co., Ltd. (3.6%)
  • Nippon Life Insurance Co. (2.8%)
  • BlackRock Fund Advisors (2.5%)
  • The Vanguard Group, Inc. (2.3%)
  • Mitsubishi UFJ Financial Group, Inc. (1.3%)
  • Daiwa Asset Management Co. Ltd. (1.3%)

Contact Details

Related Companies

  • MCPP Innovation LLC
  • Mitsubishi Chemical Lucite Group Ltd.
  • Diamond Edge Ventures, Inc.
  • Mitsubishi Chemical Holdings Board Incentive Plan
  • Verbatim Corp.
  • Mitsubishi Chemical Imaging Corp.
  • MEP Technical Center Asia Ltd.
  • MCC Group Holdings (UK) Ltd.
  • Life Science Institute, Inc.
  • Mitsubishi Chemical Holdings Europe GmbH
  • AmperVertice Lda.
  • Mitsubishi Plastics Agricultural Film Technology Wuxi Co. Ltd.
  • Ryoukou Industrial Co. Ltd.
  • Mitsubishi Chemical Analysis Co. Ltd.
  • Rhombic Corp. (Japan)
  • Verbatim Southern Africa
  • Mitsubishi Chemical Holdings (Beijing) Co. Ltd.
  • Tai Young High Tech Co. Ltd.
  • MCC PTA Asia Pacific Pte Ltd.
  • Mitsubishi Chemical Holdings America, Inc.
  • Advanced Plastics Compounds Singapore Pte Ltd.
  • PT Mitsubishi Chemical Indonesia
  • Yoshitomi Engineering Ltd.
  • Mitsubishi Chemical Hldgs Business Association
  • Kaiteki Institute, Inc.
  • Mitsubishi Chemical Infonics Pte Ltd.
  • Nihon Gosei Sangyo KK
  • Ryoju Corp.
  • Mitsubishi Chemical Agri, Inc.
  • Japan Unipet Co. Ltd.


  • Evonik Industries AG
  • Sumitomo Chemical Co., Ltd.
  • DuPont de Nemours, Inc.
  • Eastman Chemical Company
  • LG Chem Ltd.
  • Arkema SA
  • Kolon Industries, Inc.
  • Kolon Life Science Inc.
  • Sinochem International Corporation Class A
  • Celanese Corporation
  • Polyplex (Thailand) Public Co. Ltd.
  • Covestro AG
  • UFlex Limited
  • Adamas Pharmaceuticals, Inc.
  • Acorda Therapeutics, Inc.
  • Linde plc
  • Fuwei Films (Holdings) Co., Ltd.
  • Cytokinetics, Incorporated
  • Shenzhen Capchem Technology Co., Ltd. Class A
  • Tredegar Corporation
  • Voyager Therapeutics, Inc.
  • Chemocentryx, Inc.
  • FibroGen, Inc.
  • Aquestive Therapeutics, Inc.
  • Valneva SE
  • BiondVax Pharmaceuticals Ltd. Sponsored ADR
  • GrafTech International Ltd.
  • Green Seal Holding Ltd.
  • Axovant Gene Therapies Ltd.
  • OCI Partners LP
Last Updated on 30 Mar, 2020

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this monthThis is your last free article this month

Stay ahead with our exclusives on Asia;
the most dynamic market in the world.

Stay ahead with our exclusives on Asia

Get trusted insights from experts within Asia itself.

Get trusted insights from experts
within Asia itself.

Get Unlimited access

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this month

This is your last free article this month

Stay ahead with our exclusives on Asia; the most
dynamic market in the world

Get trusted insights from experts
within Asia itself.

Try 3 months for $9

Offer ends April 30th

Your trial period has expired

You need a subscription to...

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers and subscribe

Your full access to the Nikkei Asian Review has expired

You need a subscription to:

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers
NAR on print phone, device, and tablet media